Sentence examples for in each formulation from inspiring English sources
Protein levels that meet the ducks amino acid requirements may vary slightly, depending upon the amino acid content of the ingredients used in each formulation.
After 30 days of static culture, VFF ECM production and phenotype in each formulation was assessed biochemically and histologically.
It is found that true solution for characteristic equation depends on the specified boundary condition while spurious one is embedded in each formulation.
The pharmacokinetic study showed that fu of CyA in each formulation correlated with its in vivo performance determined by pharmacokinetic parameters: the lower fu of the formulation, translated to a higher area under the concentration versus time curve (AUC), and a lower clearance (CL) and volume of distribution (Vd).
Therefore, because of various components in each formulation, swelling ratio was measured at different time points.
The concentration of particles (particles per mL) in each formulation was evaluated by nanoparticle tracking analysis (NTA) with a NanoSight LM10 system (NanoSight, Amesbury, UK), equipped with a sample chamber and a 640-nm laser.
In vitro release profile of KSL-W from the PLGA microspheres suspended in PBS and in 20% Pluronic F127 gel was performed in triplicate for each formulation using a six-station Franz diffusion cell.
A relationship was established between the mean anti-Bm86 IgG1 levels in mice and the protection reached in cattle with each formulation, giving a correlation coefficient of 0.99.
Relationships between the specific level of anti-Bm86 IgG subclasses in mice and the protection level achieved in cattle with each formulation (expressed as efficacy) were also established by correlation analyses.
In in vitro animal studies, each formulation demonstrated a markedly different toxicity profile, with iron sucrose being the most toxic, followed by iron gluconate, then iron dextran.
Use of the three commercial formulations pentaBDE, octaBDE, and decaBDE (named for the average number of bromines in the congeners of each formulation)—increased in the United States from the 1980s until 2004, when U.S. manufacturing of penta and octaBDE was voluntarily phased out due to concerns about toxicity (U.S. EPA 2008, 2012).
